⌘K
Loading ticker…
As of 2026-08-25, Imunon, Inc. Common Stock (IMNN) has a 3-month relative strength percentile of 17 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 34. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.1%, relative volume 1.02×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
IMNN is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -4.2% / -41.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
IMNN is held by 2 ETFs as of Mar 2026. Top owner: VXF at 0.00% weight, $47K notional.
Held by 2 ETFs · $51K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $47K | — |
| VTIVanguard Total Stock Market ETF | 0.00% | $3K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IMNN Jan avg: -6.69% median: -9.85% win: 25% σ: 17.37% n: 4 2022-09-22 → 2026-07-31 | IMNN Feb avg: 27.33% median: -0.74% win: 50% σ: 62.56% n: 4 2022-09-22 → 2026-07-31 | IMNN Mar avg: 9.88% median: 4.17% win: 50% σ: 26.49% n: 4 2022-09-22 → 2026-07-31 | IMNN Apr avg: -9.47% median: -11.87% win: 25% σ: 12.85% n: 4 2022-09-22 → 2026-07-31 | IMNN May avg: 43.30% median: -0.14% win: 50% σ: 102.99% n: 4 2022-09-22 → 2026-07-31 | IMNN Jun avg: -24.09% median: -18.90% win: 25% σ: 32.08% n: 4 2022-09-22 → 2026-07-31 | IMNN Jul avg: -6.88% median: -6.50% win: 25% σ: 19.61% n: 4 2022-09-22 → 2026-07-31 | IMNN Aug avg: -11.12% median: -14.81% win: 0% σ: 9.06% n: 3 2022-09-22 → 2026-07-31 (current) | IMNN Sep avg: -12.73% median: -10.84% win: 0% σ: 6.34% n: 4 2022-09-22 → 2026-07-31 | IMNN Oct avg: -8.23% median: -10.71% win: 25% σ: 6.07% n: 4 2022-09-22 → 2026-07-31 | IMNN Nov avg: -8.47% median: -9.23% win: 0% σ: 1.68% n: 4 2022-09-22 → 2026-07-31 | IMNN Dec avg: -6.05% median: -6.23% win: 25% σ: 15.20% n: 4 2022-09-22 → 2026-07-31 |